Research summary
A review discusses antibody–siRNA conjugates as an investigational anti-leukemic strategy.
Authors
Cite this work
Jogender Tushir-Singh (2017). Antibody-siRNA conjugates: drugging the undruggable for anti-leukemic therapy. Expert opinion on biological therapy, 325-338. https://doi.org/10.1080/14712598.2017.1273344